174 related articles for article (PubMed ID: 17219016)
1. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD.
Schimmelmann BG; Friedel S; Dempfle A; Warnke A; Lesch KP; Walitza S; Renner TJ; Romanos M; Herpertz-Dahlmann B; Linder M; Schäfer H; Seitz C; Palmason H; Freitag C; Meyer J; Konrad K; Hinney A; Hebebrand J
J Neural Transm (Vienna); 2007; 114(4):523-6. PubMed ID: 17219016
[TBL] [Abstract][Full Text] [Related]
2. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD.
Kent L; Green E; Hawi Z; Kirley A; Dudbridge F; Lowe N; Raybould R; Langley K; Bray N; Fitzgerald M; Owen MJ; O'Donovan MC; Gill M; Thapar A; Craddock N
Mol Psychiatry; 2005 Oct; 10(10):939-43. PubMed ID: 15940292
[TBL] [Abstract][Full Text] [Related]
3. BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.
Zeni CP; Tramontina S; Aguiar BW; Salatino-Oliveira A; Pheula GF; Sharma A; Stertz L; Moreira Maia CR; Hutz M; Kapczinski FP; Rohde LA
Acta Psychiatr Scand; 2016 Sep; 134(3):268-74. PubMed ID: 27209073
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations.
Sánchez-Mora C; Ribasés M; Ramos-Quiroga JA; Casas M; Bosch R; Boreatti-Hümmer A; Heine M; Jacob CP; Lesch KP; Fasmer OB; Knappskog PM; Kooij JJS; Kan C; Buitelaar JK; Mick E; Asherson P; Faraone SV; Franke B; Johansson S; Haavik J; Reif A; Bayés M; Cormand B
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):512-523. PubMed ID: 19603419
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naïve Han Chinese sample.
Li H; Liu L; Tang Y; Ji N; Yang L; Qian Q; Wang Y
Psychiatry Res; 2014 Jul; 217(3):191-7. PubMed ID: 24713358
[TBL] [Abstract][Full Text] [Related]
6. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples.
Xu X; Mill J; Zhou K; Brookes K; Chen CK; Asherson P
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):83-6. PubMed ID: 17044097
[TBL] [Abstract][Full Text] [Related]
7. Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.
Kim BN; Cummins TD; Kim JW; Bellgrove MA; Hong SB; Song SH; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1399-410. PubMed ID: 21733227
[TBL] [Abstract][Full Text] [Related]
8. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms.
Aureli A; Del Beato T; Sebastiani P; Marimpietri A; Melillo CV; Sechi E; Di Loreto S
Int J Immunopathol Pharmacol; 2010; 23(3):873-80. PubMed ID: 20943059
[TBL] [Abstract][Full Text] [Related]
9. The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder.
Park S; Kim BN; Kim JW; Jung YK; Lee J; Shin MS; Yoo HJ; Cho SC
Behav Brain Funct; 2014 Nov; 10():43. PubMed ID: 25425456
[TBL] [Abstract][Full Text] [Related]
10. Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder.
Lee J; Laurin N; Crosbie J; Ickowicz A; Pathare T; Malone M; Tannock R; Kennedy JL; Schachar R; Barr CL
Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):976-81. PubMed ID: 17918236
[TBL] [Abstract][Full Text] [Related]
11. Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity.
Bergman O; Westberg L; Lichtenstein P; Eriksson E; Larsson H
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1367-76. PubMed ID: 21466746
[TBL] [Abstract][Full Text] [Related]
12. Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples.
de Castro-Catala M; van Nierop M; Barrantes-Vidal N; Cristóbal-Narváez P; Sheinbaum T; Kwapil TR; Peña E; Jacobs N; Derom C; Thiery E; van Os J; van Winkel R; Rosa A
J Psychiatr Res; 2016 Dec; 83():121-129. PubMed ID: 27596955
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
14. Association between BDNF gene polymorphisms and attention deficit hyperactivity disorder in Korean children.
Kwon HJ; Ha M; Jin HJ; Hyun JK; Shim SH; Paik KC; Park WS; Lim MH
Genet Test Mol Biomarkers; 2015 Jul; 19(7):366-71. PubMed ID: 25950609
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.
Lohoff FW; Sander T; Ferraro TN; Dahl JP; Gallinat J; Berrettini WH
Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):51-3. PubMed ID: 16152572
[TBL] [Abstract][Full Text] [Related]
16. BDNF Val66Met genetic variation and its plasma level in patients with morbid obesity: A case-control study.
Zamani M; Hosseini SV; Behrouj H; Erfani M; Dastghaib S; Ahmadi M; Shamsdin SA; Mokarram P
Gene; 2019 Jul; 705():51-54. PubMed ID: 31004714
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between single nucleotide polymorphisms of neurotrophic factors and executive function characteristics in children with attention deficit hyperactivity disorder].
Wang N; Wang Z; Yan F; Fu W
Wei Sheng Yan Jiu; 2019 Jul; 48(4):577-582. PubMed ID: 31601338
[TBL] [Abstract][Full Text] [Related]
18. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder.
De Luca V; Strauss J; Semeralul M; Huang S; Li PP; Warsh JJ; Kennedy JL; Wong AH
Neurosci Lett; 2008 Aug; 441(2):229-32. PubMed ID: 18606495
[TBL] [Abstract][Full Text] [Related]
19. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Is a Risk Factor for Attention-Deficit Hyperactivity Disorder in a Turkish Sample.
Ozturk O; Basay BK; Buber A; Basay O; Alacam H; Bacanlı A; Yılmaz ŞG; Erdal ME; Herken H; Ercan ES
Psychiatry Investig; 2016 Sep; 13(5):518-525. PubMed ID: 27757130
[TBL] [Abstract][Full Text] [Related]
20. Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder.
Lanktree M; Squassina A; Krinsky M; Strauss J; Jain U; Macciardi F; Kennedy JL; Muglia P
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):945-51. PubMed ID: 18286632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
